HEADER TRANSFERASE/TRANSFERASE INHIBITOR 21-AUG-13 4MCC TITLE HINTRMD IN COMPLEX WITH N-[4-(AMINOMETHYL)BENZYL]-4-OXO-3,4- TITLE 2 DIHYDROTHIENO[2,3-D]PYRIMIDINE-5-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: M1G-METHYLTRANSFERASE, TRNA [GM37] METHYLTRANSFERASE; COMPND 5 EC: 2.1.1.228; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HAEMOPHILUS INFLUENZAE; SOURCE 3 ORGANISM_TAXID: 71421; SOURCE 4 STRAIN: ATCC51907; SOURCE 5 GENE: HI_0202, TRMD; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET SYSTEM KEYWDS TREFOIL, TRMD, SAM, SAH, SINEFUNGIN, HMT, STRUCTURAL GENOMICS, N/A, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.B.OLIVIER,P.HILL REVDAT 3 28-FEB-24 4MCC 1 REMARK REVDAT 2 09-OCT-13 4MCC 1 JRNL REVDAT 1 04-SEP-13 4MCC 0 JRNL AUTH P.J.HILL,A.ABIBI,R.ALBERT,B.ANDREWS,M.M.GAGNON,N.GAO, JRNL AUTH 2 T.GREBE,L.I.HAJEC,J.HUANG,S.LIVCHAK,S.D.LAHIRI,D.C.MCKINNEY, JRNL AUTH 3 J.THRESHER,H.WANG,N.OLIVIER,E.T.BUURMAN JRNL TITL SELECTIVE INHIBITORS OF BACTERIAL T-RNA-(N(1)G37) JRNL TITL 2 METHYLTRANSFERASE (TRMD) THAT DEMONSTRATE NOVEL ORDERING OF JRNL TITL 3 THE LID DOMAIN. JRNL REF J.MED.CHEM. V. 56 7278 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23981144 JRNL DOI 10.1021/JM400718N REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.66 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 46878 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 2376 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.00 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.96 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3439 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1883 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3254 REMARK 3 BIN R VALUE (WORKING SET) : 0.1864 REMARK 3 BIN FREE R VALUE : 0.2218 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.38 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 185 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3418 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 412 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.25800 REMARK 3 B22 (A**2) : -1.25800 REMARK 3 B33 (A**2) : 2.51600 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.194 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.124 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3547 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4805 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1234 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 82 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 526 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3547 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 447 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : 1 ; 1.000 ; HARMONIC REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4275 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.22 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.96 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MCC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-AUG-13. REMARK 100 THE DEPOSITION ID IS D_1000081733. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 140 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : DIAMOND(111) REMARK 200 OPTICS : SOURCE: 3.3 UNDULATOR (UNDULATOR REMARK 200 A) MONOCHROMATOR TYPE: REMARK 200 DIAMOND(111) ENERGY RANGE 4.7-28 REMARK 200 KEV RESOLUTION ( E/E) 1 X 10 -4 REMARK 200 FLUX (PHOTONS/SEC) 2 X 1012 @ REMARK 200 12.4 KEV BEAM SIZE (HXV) FOCUSED REMARK 200 80 M X 70 M REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : PROCESS REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.20 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47060 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.949 REMARK 200 RESOLUTION RANGE LOW (A) : 119.135 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05700 REMARK 200 FOR THE DATA SET : 21.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.50 REMARK 200 R MERGE FOR SHELL (I) : 0.46200 REMARK 200 R SYM FOR SHELL (I) : 0.46200 REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN AT 10 MG/ML IN THE BUFFER: REMARK 280 20MM TRIS PH 8.0, 150 MM NACL, 10% GLYCEROL, 1MM DTT, 1MM EDTA. REMARK 280 MIXED 1:1 WITH WELL SOLUTION CONTAINING: 200 MM CAACETATE, 24% REMARK 280 PEG 400, 100 MM SODIUM ACETATE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K, PH 4.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.56750 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 29.78375 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 89.35125 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20420 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 161 REMARK 465 LYS A 162 REMARK 465 GLN A 163 REMARK 465 ALA A 164 REMARK 465 SER A 165 REMARK 465 ALA A 166 REMARK 465 GLU A 167 REMARK 465 GLU A 168 REMARK 465 ASP A 169 REMARK 465 SER A 170 REMARK 465 PHE A 171 REMARK 465 ALA A 172 REMARK 465 ASP A 173 REMARK 465 ARG A 220 REMARK 465 PRO A 221 REMARK 465 GLU A 222 REMARK 465 LEU A 223 REMARK 465 LEU A 224 REMARK 465 GLU A 225 REMARK 465 GLY A 226 REMARK 465 LEU A 227 REMARK 465 ALA A 228 REMARK 465 LEU A 229 REMARK 465 THR A 230 REMARK 465 ASP A 231 REMARK 465 GLU A 232 REMARK 465 GLN A 233 REMARK 465 ARG A 234 REMARK 465 LYS A 235 REMARK 465 LEU A 236 REMARK 465 LEU A 237 REMARK 465 LYS A 238 REMARK 465 GLU A 239 REMARK 465 ALA A 240 REMARK 465 GLN A 241 REMARK 465 ALA A 242 REMARK 465 GLU A 243 REMARK 465 HIS A 244 REMARK 465 ASN A 245 REMARK 465 SER A 246 REMARK 465 GLY B 161 REMARK 465 LYS B 162 REMARK 465 GLN B 163 REMARK 465 ALA B 164 REMARK 465 SER B 165 REMARK 465 ALA B 166 REMARK 465 GLU B 167 REMARK 465 GLU B 168 REMARK 465 ASP B 169 REMARK 465 SER B 170 REMARK 465 PHE B 171 REMARK 465 ALA B 172 REMARK 465 SER B 246 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 27 CG CD CE NZ REMARK 470 GLU A 202 CG CD OE1 OE2 REMARK 470 ILE A 204 CG1 CG2 CD1 REMARK 470 TRP A 207 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 207 CZ3 CH2 REMARK 470 ARG A 208 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 210 CG CD CE NZ REMARK 470 GLN A 211 CG CD OE1 NE2 REMARK 470 LEU A 213 CG CD1 CD2 REMARK 470 ARG A 215 CG CD NE CZ NH1 NH2 REMARK 470 TRP A 217 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 217 CZ3 CH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 115 -143.69 57.44 REMARK 500 LEU A 196 15.41 -67.02 REMARK 500 SER A 198 -115.36 -174.07 REMARK 500 GLU A 203 9.50 -67.14 REMARK 500 ILE A 204 2.96 -69.92 REMARK 500 TYR B 115 -145.13 58.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 21X A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 21X B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4MDB RELATED DB: PDB REMARK 900 COMPOUND 38 DBREF 4MCC A 1 246 UNP P43912 TRMD_HAEIN 1 246 DBREF 4MCC B 1 246 UNP P43912 TRMD_HAEIN 1 246 SEQRES 1 A 246 MET TRP ILE GLY VAL ILE SER LEU PHE PRO GLU MET PHE SEQRES 2 A 246 LYS ALA ILE THR GLU PHE GLY VAL THR GLY ARG ALA VAL SEQRES 3 A 246 LYS HIS ASN LEU LEU LYS VAL GLU CYS TRP ASN PRO ARG SEQRES 4 A 246 ASP PHE THR PHE ASP LYS HIS LYS THR VAL ASP ASP ARG SEQRES 5 A 246 PRO TYR GLY GLY GLY PRO GLY MET LEU MET MET VAL GLN SEQRES 6 A 246 PRO LEU ARG ASP ALA ILE HIS THR ALA LYS ALA ALA ALA SEQRES 7 A 246 GLY GLU GLY ALA LYS VAL ILE TYR LEU SER PRO GLN GLY SEQRES 8 A 246 ARG LYS LEU ASP GLN GLY GLY VAL THR GLU LEU ALA GLN SEQRES 9 A 246 ASN GLN LYS LEU ILE LEU VAL CYS GLY ARG TYR GLU GLY SEQRES 10 A 246 ILE ASP GLU ARG LEU ILE GLN THR GLU ILE ASP GLU GLU SEQRES 11 A 246 TRP SER ILE GLY ASP TYR VAL LEU THR GLY GLY GLU LEU SEQRES 12 A 246 PRO ALA MET THR LEU ILE ASP ALA VAL ALA ARG PHE ILE SEQRES 13 A 246 PRO GLY VAL LEU GLY LYS GLN ALA SER ALA GLU GLU ASP SEQRES 14 A 246 SER PHE ALA ASP GLY LEU LEU ASP CYS PRO HIS TYR THR SEQRES 15 A 246 ARG PRO GLU VAL LEU GLU GLY LEU THR VAL PRO PRO VAL SEQRES 16 A 246 LEU MET SER GLY HIS HIS GLU GLU ILE ARG LYS TRP ARG SEQRES 17 A 246 LEU LYS GLN SER LEU GLN ARG THR TRP LEU ARG ARG PRO SEQRES 18 A 246 GLU LEU LEU GLU GLY LEU ALA LEU THR ASP GLU GLN ARG SEQRES 19 A 246 LYS LEU LEU LYS GLU ALA GLN ALA GLU HIS ASN SER SEQRES 1 B 246 MET TRP ILE GLY VAL ILE SER LEU PHE PRO GLU MET PHE SEQRES 2 B 246 LYS ALA ILE THR GLU PHE GLY VAL THR GLY ARG ALA VAL SEQRES 3 B 246 LYS HIS ASN LEU LEU LYS VAL GLU CYS TRP ASN PRO ARG SEQRES 4 B 246 ASP PHE THR PHE ASP LYS HIS LYS THR VAL ASP ASP ARG SEQRES 5 B 246 PRO TYR GLY GLY GLY PRO GLY MET LEU MET MET VAL GLN SEQRES 6 B 246 PRO LEU ARG ASP ALA ILE HIS THR ALA LYS ALA ALA ALA SEQRES 7 B 246 GLY GLU GLY ALA LYS VAL ILE TYR LEU SER PRO GLN GLY SEQRES 8 B 246 ARG LYS LEU ASP GLN GLY GLY VAL THR GLU LEU ALA GLN SEQRES 9 B 246 ASN GLN LYS LEU ILE LEU VAL CYS GLY ARG TYR GLU GLY SEQRES 10 B 246 ILE ASP GLU ARG LEU ILE GLN THR GLU ILE ASP GLU GLU SEQRES 11 B 246 TRP SER ILE GLY ASP TYR VAL LEU THR GLY GLY GLU LEU SEQRES 12 B 246 PRO ALA MET THR LEU ILE ASP ALA VAL ALA ARG PHE ILE SEQRES 13 B 246 PRO GLY VAL LEU GLY LYS GLN ALA SER ALA GLU GLU ASP SEQRES 14 B 246 SER PHE ALA ASP GLY LEU LEU ASP CYS PRO HIS TYR THR SEQRES 15 B 246 ARG PRO GLU VAL LEU GLU GLY LEU THR VAL PRO PRO VAL SEQRES 16 B 246 LEU MET SER GLY HIS HIS GLU GLU ILE ARG LYS TRP ARG SEQRES 17 B 246 LEU LYS GLN SER LEU GLN ARG THR TRP LEU ARG ARG PRO SEQRES 18 B 246 GLU LEU LEU GLU GLY LEU ALA LEU THR ASP GLU GLN ARG SEQRES 19 B 246 LYS LEU LEU LYS GLU ALA GLN ALA GLU HIS ASN SER HET 21X A 301 22 HET 21X B 301 22 HETNAM 21X N-[4-(AMINOMETHYL)BENZYL]-4-OXO-3,4-DIHYDROTHIENO[2,3- HETNAM 2 21X D]PYRIMIDINE-5-CARBOXAMIDE FORMUL 3 21X 2(C15 H14 N4 O2 S) FORMUL 5 HOH *412(H2 O) HELIX 1 1 PHE A 9 MET A 12 5 4 HELIX 2 2 PHE A 13 GLU A 18 1 6 HELIX 3 3 PHE A 19 HIS A 28 1 10 HELIX 4 4 ASN A 37 THR A 42 5 6 HELIX 5 5 MET A 63 GLY A 79 1 17 HELIX 6 6 ASP A 95 ALA A 103 1 9 HELIX 7 7 ASP A 119 ILE A 127 1 9 HELIX 8 8 GLY A 141 ARG A 154 1 14 HELIX 9 9 PRO A 193 MET A 197 5 5 HELIX 10 10 HIS A 201 GLU A 203 5 3 HELIX 11 11 ILE A 204 LEU A 218 1 15 HELIX 12 12 PHE B 9 MET B 12 5 4 HELIX 13 13 PHE B 13 GLU B 18 1 6 HELIX 14 14 PHE B 19 HIS B 28 1 10 HELIX 15 15 ASN B 37 THR B 42 5 6 HELIX 16 16 MET B 63 GLY B 79 1 17 HELIX 17 17 ASP B 95 ALA B 103 1 9 HELIX 18 18 ASP B 119 ILE B 127 1 9 HELIX 19 19 GLY B 141 ARG B 154 1 14 HELIX 20 20 PRO B 193 SER B 198 5 6 HELIX 21 21 HIS B 200 ARG B 220 1 21 HELIX 22 22 PRO B 221 GLY B 226 1 6 HELIX 23 23 THR B 230 HIS B 244 1 15 SHEET 1 A 6 LYS A 32 TRP A 36 0 SHEET 2 A 6 TRP A 2 ILE A 6 1 N ILE A 3 O LYS A 32 SHEET 3 A 6 LYS A 107 CYS A 112 1 O LEU A 110 N GLY A 4 SHEET 4 A 6 LYS A 83 LEU A 87 1 N ILE A 85 O ILE A 109 SHEET 5 A 6 GLU A 129 SER A 132 1 O GLU A 129 N TYR A 86 SHEET 6 A 6 ARG A 92 LYS A 93 1 N ARG A 92 O SER A 132 SHEET 1 B 2 ASP A 50 ASP A 51 0 SHEET 2 B 2 LEU A 61 MET A 62 -1 O LEU A 61 N ASP A 51 SHEET 1 C 2 VAL A 186 LEU A 187 0 SHEET 2 C 2 LEU A 190 THR A 191 -1 O LEU A 190 N LEU A 187 SHEET 1 D 6 LYS B 32 TRP B 36 0 SHEET 2 D 6 TRP B 2 ILE B 6 1 N ILE B 3 O LYS B 32 SHEET 3 D 6 LYS B 107 CYS B 112 1 O LEU B 110 N GLY B 4 SHEET 4 D 6 LYS B 83 LEU B 87 1 N ILE B 85 O ILE B 109 SHEET 5 D 6 GLU B 129 SER B 132 1 O GLU B 129 N TYR B 86 SHEET 6 D 6 ARG B 92 LYS B 93 1 N ARG B 92 O SER B 132 SHEET 1 E 2 ASP B 50 ASP B 51 0 SHEET 2 E 2 LEU B 61 MET B 62 -1 O LEU B 61 N ASP B 51 SHEET 1 F 2 VAL B 186 LEU B 187 0 SHEET 2 F 2 LEU B 190 THR B 191 -1 O LEU B 190 N LEU B 187 CISPEP 1 ARG A 183 PRO A 184 0 7.43 CISPEP 2 ARG B 183 PRO B 184 0 3.87 SITE 1 AC1 14 LEU A 87 SER A 88 TYR A 115 GLU A 116 SITE 2 AC1 14 SER A 132 ILE A 133 GLY A 134 TYR A 136 SITE 3 AC1 14 LEU A 138 GLY A 140 GLY A 141 PRO A 144 SITE 4 AC1 14 HOH A 572 ASP B 177 SITE 1 AC2 12 LEU B 87 SER B 88 PRO B 89 GLU B 116 SITE 2 AC2 12 SER B 132 ILE B 133 GLY B 134 TYR B 136 SITE 3 AC2 12 LEU B 138 GLY B 140 GLY B 141 PRO B 144 CRYST1 74.272 74.272 119.135 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013464 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013464 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008394 0.00000